Factor XI deficiency in women

Factor XI (FXI) deficiency is an uncommon autosomally transmitted coagulopathy found predominantly in Jewish kindreds. It is associated with variable bleeding tendency that usually manifests after trauma, surgery, or other challenges to hemostasis. Therefore, women with FXI deficiency are at risk of excessive bleeding during their menstrual periods, childbirth, and after surgery. Increased awareness and close collaboration among hematologists, obstetricians, and gynecologists and availability of management guidelines is essential to minimize these risks. This review provides data from current research in FXI deficiency and pregnancy care, menstrual problems, and the role of screening for this disorder in women referred with menorrhagia. Am. J. Hematol. 60:48–54, 1999. © 1999 Wiley‐Liss, Inc.

[1]  C. Kessler,et al.  The management of factor XI deficiency , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

[2]  D. Economides,et al.  Pregnancy in women with von Willebrand's disease or factor XI deficiency , 1998, British journal of obstetrics and gynaecology.

[3]  D. Economides,et al.  Frequency of inherited bleeding disorders in women with menorrhagia , 1998, The Lancet.

[4]  A. Laor,et al.  Bleeding predictors in factor‐XI‐deficient patients , 1997, Blood Coagulation and Fibrinolysis.

[5]  D. Economides,et al.  The obstetric experience of carriers of haemophilia , 1997 .

[6]  A. Dorozynski.  Computers prescribed to French doctors , 1996 .

[7]  J. Bonnar,et al.  Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid , 1996, BMJ.

[8]  K. Pasi,et al.  Clinical experience of factor XI deficiency: the role of fresh frozen plasma and factor XI concentrate , 1995, Haemophilia : the official journal of the World Federation of Hemophilia.

[9]  J. Hancock,et al.  Six point mutations that cause factor XI deficiency. , 1995, Blood.

[10]  E. Tuddenham,et al.  Definition of the Bleeding Tendency in Factor XI-Deficient Kindreds–A Clinical and Laboratory Study , 1995, Thrombosis and Haemostasis.

[11]  B. Colvin,et al.  Thrombogenic potential of factor XI concentrate , 1994, The Lancet.

[12]  D. Gailani.  Advances and dilemmas in factor XI. , 1994, Current opinion in hematology.

[13]  R. Ljung,et al.  Normal vaginal delivery is to be recommended for haemophilia carrier gravidae , 1994, Acta paediatrica.

[14]  J. Bonnar,et al.  The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding , 1994, Acta obstetricia et gynecologica Scandinavica.

[15]  B. Colvin,et al.  Investigation and management of haemorrhagic disorders in pregnancy. Haemostasis and Thrombosis Task Force. , 1994, Journal of Clinical Pathology.

[16]  U. Seligsohn,et al.  Factor XI Deficiency , 1993, Thrombosis and Haemostasis.

[17]  V. Koteliansky,et al.  Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. , 1993, Blood.

[18]  P. Bolton-Maggs,et al.  IDENTIFICATION AND CHARACTERIZATION OF MUTATIONS IN THE FACTOR-XI GENE OF NON-JEWISH FXI DEFICIENT PATIENTS , 1993 .

[19]  L. Winkelman,et al.  Production and Therapeutic Use of a Factor XI Concentrate from Plasma , 1992, Thrombosis and Haemostasis.

[20]  E. Davie,et al.  Factor XI deficiency in Ashkenazi Jews in Israel. , 1991, The New England journal of medicine.

[21]  D. Cooper,et al.  A molecular genetic study of factor XI deficiency. , 1991, Blood.

[22]  J. Higham,et al.  Assessment of menstrual blood loss using a pictorial chart , 1990, British journal of obstetrics and gynaecology.

[23]  B. Brenner,et al.  The Effect of Combined Factor XI Deficiency with von Willebrand Factor Abnormalities on Haemorrhagic Diathesis , 1990, Thrombosis and Haemostasis.

[24]  E. Davie,et al.  Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[25]  W. Chadduck,et al.  Postdelivery head bleeding in hemophilic neonates. Causes and management. , 1989, American journal of diseases of children.

[26]  A. McCraw,et al.  Inheritance and bleeding in factor XI deficiency , 1988, British journal of haematology.

[27]  P. Powers,et al.  Development of the human coagulation system in the full-term infant. , 1987, Blood.

[28]  J. Bonnar,et al.  The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid. , 1987, European journal of obstetrics, gynecology, and reproductive biology.

[29]  O. Ylikorkala,et al.  Primary and myoma‐associated menorrhagia: role of prostaglandins and effects of ibuprofen , 1986, British Journal of Obstetrics and Gynaecology.

[30]  D. Sinha,et al.  Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds , 1985 .

[31]  I. Fraser,et al.  A preliminary study of factors influencing perception of menstrual blood loss volume. , 1984, American journal of obstetrics and gynecology.

[32]  E. Mammen,et al.  Factor XI Deficiency , 1983, Definitions.

[33]  J. Sixma,et al.  Hemostasis in menstrual endometrium: a review. , 1982, Obstetrical & gynecological survey.

[34]  M. Andrew,et al.  Factors XI and XII and prekallikrein in sick and healthy premature infants. , 1981, The New England journal of medicine.

[35]  C. Y. Lee,et al.  Ultrasonic Evaluation of the Postpartum Uterus in the Management of Postpartum Bleeding , 1981, Obstetrics and gynecology.

[36]  Y. Gibor,et al.  Anemia and menstrual blood loss. , 1980, Obstetrical & gynecological survey.

[37]  J. Bonnar,et al.  Clinical applications of fibrinolytic inhibition in gynaecology , 1980, Journal of clinical pathology. Supplement.

[38]  J. Bonnar,et al.  LONGER THOUGH LIGHTER MENSTRUAL AND INTERMENSTURAL BLEEDING WITH COPPER AS COMPARED TO INERT INTRAUTERINE DEVICES , 1978, British Journal of Obstetrics and Gynaecology.

[39]  U. Seligsohn,et al.  Factor XI deficiency: detection and management during urological surgery. , 1978, The Journal of urology.

[40]  A. Turnbull,et al.  MEASUREMENT OF MENSTRUAL BLOOD LOSS IN PATIENTS COMPLAINING OF MENORRHAGIA , 1977, British journal of obstetrics and gynaecology.

[41]  R. Condie.  A SERIAL STUDY OF COAGULATION FACTORS XII, XI AND X IN PLASMA IN NORMAL PREGNANCY AND IN PREGNANCY COMPLICATED BY PRE‐ECLAMPSIA , 1976, British Journal of Obstetrics and Gynaecology.

[42]  P. Lundberg,et al.  TRANEXAMIC ACID AND INTRACRANIAL THROMBOSIS , 1976, The Lancet.

[43]  J. Bonnar,et al.  Letter: Prostaglandins and pre-eclampsia. , 1974, Lancet.

[44]  I. Nilsson.  Haemorrhagic and thrombotic diseases , 1974 .

[45]  W. Billewicz,et al.  SOURCES OF VARIATION IN MENSTRUAL BLOOD LOSS , 1971, The Journal of obstetrics and gynaecology of the British Commonwealth.

[46]  Pritchard Ja,et al.  Abnormalities of the third stage of labor. , 1971 .

[47]  H. L. Nossel,et al.  Factor XI (PTA) Deficiency: Surgical and Obstetric Aspects , 1970, Obstetrics and Gynecology.

[48]  R. Mibashan,et al.  A Study of Coagulation Factor Levels in Women during Labour and in Their Newborn Infants , 1966, Thrombosis and Haemostasis.

[49]  H. Vinazzer.  [On disorders of hemostasis as a cause of menorrhagia]. , 1966, Geburtshilfe und Frauenheilkunde.

[50]  L. Hallberg,et al.  Menstrual Blood Loss–A Population Study , 1966, Acta obstetricia et gynecologica Scandinavica.

[51]  B. Ramot,et al.  Heredity and Coagulation Studies in Ten Families with Factor XI (Plasma Thromboplastin Antecedent) Deficiency , 1965, British journal of haematology.

[52]  M. Hilgartner,et al.  PLASMA THROMBOPLASTIN ANTECEDENT (FACTOR XI) IN THE NEONATE. , 1965, The Journal of pediatrics.

[53]  L. Hallberg,et al.  DETERMINATION OF MENSTRUAL BLOOD LOSS. , 1964, Scandinavian journal of clinical and laboratory investigation.

[54]  R. R. Proctor,et al.  The mode of inheritance of PTA deficiency: evidence for the existence of major PTA deficiency and minor PTA deficiency. , 1961, Blood.

[55]  S. Rapaport,et al.  A simple, specific one-stage assay for plasma thromboplastin antecedent activity. , 1961, The Journal of laboratory and clinical medicine.

[56]  J. Cavins,et al.  Clinical and laboratory studies of plasma thromboplastin antecedent deficiency (PTA). , 1960, The American journal of medicine.

[57]  W. Dameshek,et al.  Plasma thromboplastin antecedent (PTA) deficiency. , 1957, A.M.A. archives of internal medicine.

[58]  R. Rosenthal,et al.  New Hemophilia-like Disease Caused by Deficiency of a Third Plasma Thromboplastin Factor.∗ , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.